CTNM
Contineum Therapeutics, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 3 ▼ 1 insider sell $62.3K at $14.94
- Feb 11 ▼ 2 insiders sell $12.8K at $16.00
- Feb 19 to Mar 2 ▼ 4 days of insider sells: $362.3K by 3 insiders, avg $15.68
- Apr 6 ▼ 1 insider sell $56.0K at $13.43
- May 1 ▼ 1 insider sell $54.7K at $13.12
- Jun 1 ▼ 1 insider sell $54.9K at $13.16
- Jun 30 to Jul 9 ▼ 4 days of insider sells: $984.9K by 3 insiders, avg $16.00
- Aug 3 ▼ 1 insider sell $40.0K at $16.01
- Sep 8 ▼ 1 insider sell $41.1K at $16.46
- Sep 29 Trading halt: Halt Resumed: CTNM, trading resumed after LUDP (Volatility…
- Sep 30 ▼ Short interest jumps 25.5% to 3.07M
- Oct 14 ▼ Baird downgrades
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $1.7M.
- InstitutionsBULLISH
Q3 2026: 12 added (0 new), 7 trimmed or exited.
- AnalystsBULLISH
11 of 14 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest +1.1% to 3.70M shares. 4.2 days to cover, ≈9.4% of shares.
- TrendDOWNTREND
13% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | DOUBLED | $35.0M |
| STATE STREET CORP | ADD | $10.9M |
| DIMENSIONAL FUND ADVISORS LP | ADD | $3.3M |
| Nuveen, LLC | ADD | $774.8K |
| ALPS ADVISORS INC | ADD | $581.9K |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | $208.0K |
| BARCLAYS PLC | TRIM | $203.5K |
| BNP PARIBAS FINANCIAL MARKETS | NEAR_EXIT | $88.0K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
14 analystsPrice is below the lowest target. Median implies +128%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 15, 2026 | Jones Trading MAINTAIN | Buy |
| Oct 14, 2026 | Baird DOWNGRADE | Neutral |
| Sep 28, 2026 | Morgan Stanley MAINTAIN | Equal-Weight |
| Sep 15, 2026 | Jones Trading MAINTAIN | Buy |
| Sep 15, 2026 | Baird MAINTAIN | Outperform |
| Jul 31, 2026 | RBC Capital MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Stengone Carmine N. CEO and President Sep 8, 2026 | EXERCISE | $2.5K |
Stengone Carmine N. CEO and President Sep 8, 2026 | SELL | $41.1K |
Stengone Carmine N. CEO and President Aug 3, 2026 | EXERCISE | $2.5K |
Stengone Carmine N. CEO and President Aug 3, 2026 | SELL | $40.0K |
Lorrain Daniel S. Chief Scientific Officer Jul 9, 2026 | EXERCISE | $25.25 |
Lorrain Daniel S. Chief Scientific Officer Jul 9, 2026 | SELL | $400.00 |
Stengone Carmine N. CEO and President Jul 8, 2026 | EXERCISE | $2.5K |
Stengone Carmine N. CEO and President Jul 8, 2026 | SELL | $40.0K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.47 | -$0.54–-$0.39 | -4.4% | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026| Sep 29, 2026 | Volatility Pause | Resumed |
SecBot reports
14 filings · 0 bullish · 0 bearish · 1 mixed · 13 neutral- NEUTRAL SC 13G/ANov 16, 2026
Janus Henderson Group Ltd. filed an amended Schedule 13G disclosing a 4.6% passive stake in Contineum Therapeutics as of September 30, 2026, down from a prior filing. The stake consists of 1,723,312 shares of Class A common stock, and the filing reaffirms passive intent with no control influence.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL INST-CLUSTERNov 10, 2026
Four asset managers added to their CTNM positions in Q3 2026, totaling $577K in net buying, while…
The cluster is small and lacks insider corroboration, suggesting limited conviction. Monitor next quarter's 13F for follow-through and watch for any insider buying or pipeline catalysts that could…
- NEUTRAL SC 13G/ANov 6, 2026
Johnson & Johnson Innovation-JJDC (a J&J subsidiary) filed an amended Schedule 13G disclosing a…
J&J's increased passive stake adds to a cluster of recent institutional 13G filings (Fidelity, Squadron Capital, Franklin Templeton) over the past two weeks. Monitor for any conversion to a 13D or…
- NEUTRAL SC 13GNov 5, 2026
FMR LLC (Fidelity) disclosed a 7.9% passive stake in Contineum Therapeutics as of September 30…
The cluster of four passive 13G filings within 14 days suggests growing institutional interest in CTNM at current levels. Monitor for additional 13G filings or a potential 13D conversion if any…
All CTNM filing & press-release reports (14)
- SC 13G/A reportNov 16, 2026
- INST-CLUSTER reportNov 10, 2026
- SC 13G/A reportNov 6, 2026
- SC 13G reportNov 5, 2026
- 144 reportNov 4, 2026
- 8-K reportNov 3, 2026
- SC 13G reportOct 28, 2026
- SC 13G/A reportOct 28, 2026
- SC 13G reportOct 22, 2026
- INST-CLUSTER reportSep 22, 2026
- CLUSTER reportJul 8, 2026
- CLUSTER reportJul 2, 2026
- CLUSTER reportJul 1, 2026
- 8-K reportMar 5, 2026